EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

User evaluation of the Hypo‐METRICS app: A tool for real‐time symptom reporting of hypoglycaemia

Monika Cigler iD, Uffe Søholm iD, Melanie Broadley iD, François Pouwer iD, Evertine J Abbink iD, Namam Ali iD, Bastiaan E de Galan iD, Eric Renard iD, Mark Evans iD, Julie Maria Bøggild Brøsen iD, Ulrik Pedersen-Bjergaard iD, Rory J Mc Crimmon iD und 8 weitere

Diabetic Medicine · 2026

DOI: 10.1111/dme.70185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetic Medicine, 2026. Verfasst von Monika Cigler und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Hypoglycemia, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Mobile Applications. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovative Medicines Initiative 2, Grant agreement 777460, EU Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Hypoglycaemia remains a barrier to optimal diabetes management, with few tools for capturing real‐time person‐reported hypoglycaemia (PRH). This study evaluated the Hypo‐METRICS app, originally developed for a multinational 10‐week prospective study of hypoglycaemia. It enables real‐time reporting of hypoglycaemic episodes and their impact on daily functioning using Ecological Momentary Assessment (EMA), thereby overcoming limitations of retrospective self reports.

Methods

After completing the Hypo‐METRICS study, 120 participants with type 1 diabetes mellitus (T1D) or type 2 diabetes mellitus (T2D) from Austria, Denmark, the Netherlands, and the United Kingdom were invited to complete a web‐based questionnaire assessing app content, functionality, intervention effects, user engagement and the influence of the Covid‐19 pandemic.

Results

Ninety‐six participants (80%; 29 T1D, 67 T2D) completed the questionnaire (40% women; mean age 57.2 ± 16.1 years; 26% impaired hypoglycaemia awareness; HbA1c 60 ± 13 mmol/mol (7.6 ± 1.1%); diabetes duration 20.4 ± 11.3 years). App content and functionality were rated highly (>8/10 and >7/10, respectively). Some reported declining engagement, likely due to study length. COVID‐19 had a minimal impact on app use.

Conclusions

The Hypo‐METRICS app was well accepted, with strong ratings for usability and functionality. Given its unique strengths, the app has the potential to become an essential instrument for researchers aiming to capture the real‐world burden and impact of hypoglycaemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoglycemiaDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Mobile ApplicationsHumansFemaleMaleMiddle AgedCOVID-19AgedSurveys and QuestionnairesAdultEcological Momentary AssessmentSARS-CoV-2NetherlandsProspective StudiesAustriaUnited KingdomSelf ReportHypoglycemic Agents

Stichwörter der Autor:innen

CGMHypo‐METRICSappcontinuous glucose monitoringdiabetesdiabetes managementhypoglycaemia

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Department of Psychology, University of Southern Denmark, Odense, Denmark.
  • School of Psychology, Institute for Health Transformation, Deakin University, Geelong, Victoria, Australia.
  • The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Carlton, Victoria, Australia.
  • Steno Diabetes Center Odense (SDCO), Odense, Denmark.
  • Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.

ORCID-Profile: Monika Cigler, Uffe Søholm, Melanie Broadley, François Pouwer, Evertine J Abbink, Namam Ali, Bastiaan E de Galan, Eric Renard, Mark Evans, Julie Maria Bøggild Brøsen, Ulrik Pedersen-Bjergaard, Rory J Mc Crimmon, Simon Heller, Sharon Caunt, Stephanie A Amiel, Patrick Divilly, Natalie Zaremba, Pratik Choudhary, Julia K Mader

Förderung

  • Innovative Medicines Initiative 2
  • Grant agreement 777460
  • EU Horizon 2020
  • EFPIA
  • European Federation of Pharmaceutical Industries and Associations

Zitieren

APA

Cigler, M., Søholm, U., Broadley, M., Pouwer, F., Abbink, E. J., Ali, N., de Galan, B. E., Renard, E., Evans, M., Bøggild Brøsen, J. M., Pedersen-Bjergaard, U., Mc Crimmon, R. J., Heller, S., Caunt, S., Amiel, S. A., Divilly, P., Zaremba, N., Choudhary, P., Mader, J. K., & Hypo‐RESOLVE consortium (2026). User evaluation of the Hypo‐METRICS app: A tool for real‐time symptom reporting of hypoglycaemia. Diabetic Medicine. https://doi.org/10.1111/dme.70185

Vancouver

Cigler M, Søholm U, Broadley M, Pouwer F, Abbink EJ, Ali N, et al. User evaluation of the Hypo‐METRICS app: A tool for real‐time symptom reporting of hypoglycaemia. Diabetic Medicine. 2026. doi:10.1111/dme.70185

BibTeX
@article{Cigler2026,
  author = {Cigler, Monika and Søholm, Uffe and Broadley, Melanie and Pouwer, François and Abbink, Evertine J and Ali, Namam and de Galan, Bastiaan E and Renard, Eric and Evans, Mark and Bøggild Brøsen, Julie Maria and Pedersen-Bjergaard, Ulrik and Mc Crimmon, Rory J and Heller, Simon and Caunt, Sharon and Amiel, Stephanie A and Divilly, Patrick and Zaremba, Natalie and Choudhary, Pratik and Mader, Julia K and Hypo‐RESOLVE consortium, Hypo‐RESOLVE consortium},
  title = {User evaluation of the Hypo‐METRICS app: A tool for real‐time symptom reporting of hypoglycaemia},
  journal = {Diabetic Medicine},
  year = {2026},
  doi = {10.1111/dme.70185}
}
Kostenlos starten →